Vividion Therapeutics is Drug Discovery in United States that focus on global selectivity profiling business. Founded in 2013. They cover business area such as developer, transformative treatment, patient, serious illness, chemical proteomic, difficult target, healthcare professional, artifact, proteome-wide drug interaction map, simultaneous target engagement, global selectivity profiling.
2013
( 11 years old in 2024 )
Global Selectivity Profiling
-
5820 Nancy Ridge Drive
San Diego, CA 92121
United States
Private
developertransformative treatmentpatientserious illnesschemical proteomicdifficult targethealthcare professionalartifactproteome-wide drug interaction mapsimultaneous target engagementglobal selectivity profiling
* We use standard office opening hours in near Vividion Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Vividion Therapeutics is Drug Discovery business from United States that founded in 2013 (11 years old in 2024), Vividion Therapeutics business is focusing on Global Selectivity Profiling.
Vividion Therapeutics headquarter office and corporate office address is located in 5820 Nancy Ridge Drive San Diego, CA 92121 United States.
Vividion Therapeutics was founded in United States.
In 2024, Vividion Therapeutics is currently focus on global selectivity profiling sector.
Above is snippet of Google Trends for "global selectivity profiling" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Vividion Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
